OncoCyte Overview
Latest P/E ratio for OncoCyte: -2.26 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-2.26
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, 0KCC.L shows a P/E ratio of -2.26. That is below the sector sector average of 25.13. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 25.13. OncoCyte is at -2.26, which is lower that average. That is roughly 109.0% below the sector mean. Use the comparison chart on this page to see how 0KCC.L stacks up against individual peers as well.
Investors watch 0KCC.L's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. OncoCyte's latest reading is -2.26. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has OncoCyte's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -2.26) with ownership activity and broader fundamentals.
